Once Daily. Oral.
Non-opioid.

About the Investigational Drug

Traditionally, HA pain management often involves the use of nonselective NSAIDs and opioids. However, long-term use of these medications can result in increased risk of GI bleeding (NSAIDs) and dependency (opioids).

Researchers in the RESET-HA study are evaluating an investigational drug – a cyclooxygenase-2 (COX-2) selective NSAID – which is designed to potentially help reduce pain caused by HA and improve physical function in a way that is different from other medications.